Analysts Viewpoint Insider Sale Alert: Janux Therapeutics Inc [JANX] – Is it Time to sell? Janux Therapeutics Inc’s recently made public that its Chief Business Officer Meyer Andrew Hollman unloaded Company’s shares for reported $0.11
Analysts Viewpoint Janux Therapeutics Inc [JANX] Meyer Andrew Hollman sells 3,333 Shares for $0.11 million Janux Therapeutics Inc’s recent filing unveils that its Chief Business Officer Meyer Andrew Hollman unloaded Company’s shares for reported $0.11